Prevest Denpro Ltd.
| BSE: 543363 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE0GAO01018 |
| BSE 00:00 | 29 Jun | 285.00 |
-5.00 (-1.72%) |
OPEN
289.80 |
HIGH
290.00 |
LOW
285.00 |
| NSE 05:30 | 01 Jan | Prevest Denpro Ltd |
| OPEN | 289.80 |
| PREVIOUS CLOSE | 290.00 |
| VOLUME | 5200 |
| 52-Week high | 478.15 |
| 52-Week low | 170.65 |
| P/E | 29.56 |
| Mkt Cap.(Rs cr) | 342 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Prevest Denpro Ltd. (PREVESTDENPRO) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 514.85 | -6.45 | -1.24 | 3112.91 |
| Cipla | 945.60 | 0.90 | 0.10 | 2468.28 |
| Dr Reddy's Labs | 4363.30 | -11.35 | -0.26 | 2186.40 |
| Sun Pharma.Inds. | 838.15 | 10.20 | 1.23 | 2139.70 |
| Divi's Lab. | 3584.50 | -29.45 | -0.81 | 1954.72 |
| Glaxosmi. Pharma | 1497.90 | -0.65 | -0.04 | 1690.53 |
| Alkem Lab | 2972.85 | -17.45 | -0.58 | 1685.08 |
| Glenmark Pharma. | 389.00 | 1.55 | 0.40 | 1649.45 |
| Zydus Lifesci. | 356.05 | -1.70 | -0.48 | 1476.20 |
| Lupin | 620.20 | -13.35 | -2.11 | 1258.62 |
| Alembic Pharma | 738.85 | 0.60 | 0.08 | 1175.39 |
| Ipca Labs. | 896.35 | -5.85 | -0.65 | 1140.77 |
| Torrent Pharma. | 2840.30 | -41.85 | -1.45 | 1137.85 |
| Gland Pharma | 2652.25 | 4.60 | 0.17 | 997.01 |
| Sanofi India | 6420.50 | 14.35 | 0.22 | 944.40 |
| Laurus Labs | 466.60 | -2.10 | -0.45 | 750.09 |
| Abbott India | 18964.30 | 838.20 | 4.62 | 690.69 |
| Ajanta Pharma | 1222.85 | -18.05 | -1.45 | 675.64 |
| Wockhardt | 209.65 | -3.05 | -1.43 | 593.29 |
| Granules India | 276.80 | 1.40 | 0.51 | 552.78 |
Quick Links for Prevest Denpro:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
